Procedure

The ethical clearance for the study was obtained from the Institution Ethics Committee. After obtaining the necessary permission, the study was initiated. To recruit patients, the clinical status of 165 patients was reviewed. Out of whom, 59 patients met the inclusion and exclusion criteria laid down for the study. Those who met the inclusion criteria laid down for the study were approached individually for the written informed consent. Of them, forty patients (67.8%) gave written informed consent to participate in the study. These patients were screened using MINI. Three patients were screened out since they were positive for psychotic disorders on MINI. Two patients dropped out. The remaining 35 patients were administered LSC-R. The assessments were administered individually and privacy and confidentiality were ensured.

Women in the community were approached individually for participation in the study. Those who gave written informed consent for participation in the study were screened using K10 and ASSIST. Two women were not included in the study after initial screening, as they were found to be psychologically distressed. They were informed about the appropriate treatment facilities after taking their consent for the same. A total of sixty participants meeting the criteria for the study were administered LSC-R. All the assessments were administered individually and privacy and confidentiality were ensured.